Medical Food to Stop the Progression of Parkinson’s Disease
Don McCammon
Unaffiliated, Orlando, Florida, USA.
DOI: 10.4236/apd.2014.32003   PDF    HTML   XML   7,431 Downloads   10,668 Views   Citations

Abstract

No progress has been made in the development of drugs to stop the progression of Parkinson’s Disease. Here the author has presented a novel approach to stopping the disease using a dietary supplement primarily composed of Mannitol. In vivo animal studies have shown that Mannitol was able to break up alpha-synuclein clusters and restore functioning in transgenic drosophila and mice. The author, who has Parkinson’s, used himself as a subject and was able to achieve similar results.

Keywords

Mannitol

Share and Cite:

McCammon, D. (2014) Medical Food to Stop the Progression of Parkinson’s Disease. Advances in Parkinson's Disease, 3, 10-13. doi: 10.4236/apd.2014.32003.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Surguchov, A. (2008) Molecular and Cellular Biology of Synucleins. International Review of Cell and Molecular Biology, 270, 225-317. http://dx.doi.org/10.1016/S1937-6448(08)01406-8
[2] Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) A-Synuclein Occurs Physiologically as a Helically Folded Tetramer That Resists Aggregation. Nature, 477, 107-110. http://dx.doi.org/10.1038/nature10324
[3] Orenstein, S.J., Kuo, S.H., Tasset, L., Loga, H., et al. (2013) Interplay of LRRK@2 with Chaperone-mEdiated Autophagy. Nature Neuroscience, 394-406. http://dx.doi.org/10.1038/nn.3350
[4] American Friends of Tel Aviv University. Artificial Sweetener a Potential Treatment for Parkinson’s Disease. ScienceDaily. ScienceDaily, 17 June 2013.
www.sciencedaily.com/releases/2013/06/130617122401.htm
[5] Shaltiel-Karyo, R., Frenkel-Pinter, M., Rockenstein, E., Patrick, C., Levy-Sakin, M., Schiller, A., Egoz-Matia, N., Masliah, E., Segal, D. and Gazit. E. (2013) A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent-Synuclein (-syn) Aggregation Inhibitor: A NOVEL DUAL MECHANISM OF MANNITOL FOR THE TREATMENT OF PARKINSON DISEASE (PD). Journal of Biological Chemistry, 288, 17579.
http://dx.doi.org/10.1074/jbc.M112.434787

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.